India Menopause Market Size & Outlook, 2025-2030
Global Market
Related Markets
India menopause market highlights
- The India menopause market generated a revenue of USD 1,026.3 million in 2024 and is expected to reach USD 1,672.7 million by 2030.
- The India market is expected to grow at a CAGR of 8.5% from 2025 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2024.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2024 | USD 1,026.3 million |
| Market revenue in 2030 | USD 1,672.7 million |
| Growth rate | 8.5% (CAGR from 2025 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal, Non-Hormonal, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, India accounted for 5.8% of the global menopause market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China menopause market is projected to lead the regional market in terms of revenue in 2030.
- Malaysia is the fastest growing regional market in Asia Pacific and is projected to reach USD 91.3 million by 2030.
According to a study published by the Journal of Mid-Life Health in March 2019, menopausal age in Indian women is around 4-5 years lower than women in western countries, leading to early onset of hot flashes.
There has been an increase in awareness about women’s health in the country, along with a growing trend of adopting Ayurvedic supplements such as Shatavari for easing symptoms such as hot flashes, as well as Ashwagandha-based supplements. The early onset of menopause and increasing adoption of dietary supplements are likely to boost the demand for dietary supplements in the country.
No credit card required*
Publish Date: May 30, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22,822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | www.drreddys.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Nestle SA | View profile | 270,000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | www.nestle.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Theramex | View profile | 251-500 | London, England, United Kingdom, Europe | theramex.com/ |
| Rainbow Light Nutritional Systems | View profile | 51-100 | Santa Cruz, California, United States, North America | www.rainbowlight.com/ |
| Padagis | View profile | 251-500 | Allegan, Michigan, United States, North America | www.padagis.com |
India Menopause Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Menopause Market Outlook will help companies and investors design strategic landscapes.
Dietary Supplements was the largest segment with a revenue share of 101.57% in 2024.
Horizon Databook has segmented the India menopause market based on hormonal, non-hormonal, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published by the Journal of Mid-Life Health in March 2019, menopausal age in Indian women is around 4-5 years lower than women in western countries, leading to early onset of hot flashes.
There has been an increase in awareness about women’s health in the country, along with a growing trend of adopting Ayurvedic supplements such as Shatavari for easing symptoms such as hot flashes, as well as Ashwagandha-based supplements. The early onset of menopause and increasing adoption of dietary supplements are likely to boost the demand for dietary supplements in the country.
- India Menopause Market treatment Outlook (Revenue, USD Million , 2018-2030)
- Hormonal
- Non-Hormonal
- Dietary Supplements
Reasons to subscribe to Menopause Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Menopause Market Outlook databook
- Our clientele includes a mix of Menopause Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Menopause Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Menopause Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
India Menopause Market, 2018-2030 (US$M)
India Treatment - Menopause Market Statistics, 2024 - 2030 (US$M)
